C12N 2506/28
From vascular endothelial cells
Official title: from vascular endothelial cells
C12N2506/28 (From vascular endothelial cells) appears on 35 US grants and 68 published applications in this corpus.
Search patents in C12N- Granted patents
- 35
- Published applications
- 68
- Assignees
- 30
- Inventors
- 98
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 0 | 2 |
| 2012 | 0 | 1 |
| 2013 | 1 | 4 |
| 2014 | 0 | 2 |
| 2015 | 3 | 4 |
| 2016 | 2 | 4 |
| 2017 | 5 | 5 |
| 2018 | 4 | 5 |
| 2019 | 2 | 4 |
| 2020 | 3 | 3 |
| 2021 | 2 | 9 |
| 2022 | 1 | 9 |
| 2023 | 4 | 4 |
| 2024 | 4 | 4 |
| 2025 | 3 | 3 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Generation of kidney glomerular specific endothelial cells and methods of use20 Jan 2026US 12,527,823 B2Cornell University
- Method to engineer transplantable human tissues13 May 2025US 12,297,241 B2The Regents of the University of California
- Methods for generating hematopoietic stem cells29 Apr 2025US 12,286,643 B2The Brigham and Women S Hospital, Inc.
- Induction of pluripotent cells14 Jan 2025US 12,195,762 B2The Scripps Research Institute
- Mesenchymal stromal cells and uses related thereto24 Sep 2024US 12,097,223 B2Astellas Institute for Regenerative Medicine
- Methods for generating hematopoietic stem cells15 Jan 2026US 2026/0015583 A1The Brigham and Women S Hospital, Inc.
- Methods for generating functional hematopoietic stem cells29 May 2025US 2025/0171740 A1Children's Medical Center Corporation
- Induction of pluripotent cells1 May 2025US 2025/0136948 A1The Scripps Research Institute
- Mesenchymal stromal cells and uses related thereto20 Mar 2025US 2025/0090590 A1Astellas Institute for Regenerative Medicine
- Cell powder type cultured meat and its manufacturing method14 Nov 2024US 2024/0373887 A1UIF (University Industry Foundation), Yonsei University
Most cited
By later US patents
- Mesenchymal stromal cells and uses related thereto28US 8,962,321 B2Ocata Therapeutics, Inc. · 2015
- Induction of pluripotent cells14US 9,005,968 B2The Scripps Research Institute · 2015
- Generation of pluripotent stem cells using recombinant proteins9US 9,068,170 B2The Scripps Research Institute · 2015
- Chemical approaches for generation of induced pluripotent stem cells9US 9,394,524 B2The Scripps Research Institute · 2016
- Combined chemical and genetic approaches for generation of induced pluripotent stem cells9US 9,534,205 B2The Scripps Research Institute · 2017